Alzheimer’s Disease (Record no. 8043)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03249nam a22003017a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305192527.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220802b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1592596614 |
| International Standard Book Number | 9781592596614 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | DLC |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | WT 155 A4756 2004 |
| Classification number | RC523.A3748 2004 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Edition information | 21 |
| Classification number | 616.8’31 RIC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ralph W. Richter |
| 9 (RLIN) | 41208 |
| 222 ## - KEY TITLE | |
| Key title | abnormalities activity ADAScog Alzheimer disease Alzheimer’s disease AMPA AMPA receptor amyloid amyloid precursor protein apathy apolipoprotein Arch Neurol assessment associated behavioral brain caregiver cerebral changes cholinergic Clin clinical trials clinician cognitive function cortex deficits demented patients depression diagnosis differences differentiation disorders donepezil dose doubleblind drugs dysfunction effects efficacy elderly estrogen etal frontal frontotemporal dementia galantamine gene genetic Geriatr Psychiatry global growth factor hippocampal hNSC increased inhibitors inthe lesions levels Lewy bodies longterm markers measures memantine memory metabolism mice mild cognitive impairment MMSE mutations neurodegenerative neurofibrillary neurofibrillary tangles Neurology neurons neuroprotective neuropsychiatric symptoms neuropsychological Neurosci odor ofthe olfactory oxidative stress Parkinson’s disease pathology patients with Alzheimer’s placebo placebocontrolled plaques potential precursor protein predementia presenilin progressive receptor risk factors rivastigmine Scale score significant stem cells syndrome tacrine tau protein testosterone therapeutic therapy treatment vascular dementia |
| 245 ## - TITLE STATEMENT | |
| Title | Alzheimer’s Disease |
| Remainder of title | A Physician’s Guide to Practical Management |
| Statement of responsibility, etc. | Current Clinical Neurology |
| 250 ## - EDITION STATEMENT | |
| Edition statement | illustrated, reprint |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | New York |
| Name of publisher, distributor, etc. | Springer Science & Business Media |
| Date of publication, distribution, etc. | 2003 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 479 pages |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Alzheimer’s disease (AD) is a devastating and dehumanizing illness affecting increasingly large numbers of elderly and even middle-aged persons in a worldwide epidemic. Alzheimer’s Disease: A Physician’s Guide to Practical Management was written by selected clinicians and scientists who represent some of the world’s leading centers of excellence in AD research. The editors are proud and grateful for their profound contributions. This book is particularly designed to assist physicians and other health-care professionals in the evaluation, assessment, and treatment of individuals with AD. At the same time, by illuminating the basic scientific background, we hope to provide state-of-the art information about the disease and possible future therapeutic strategies. The recent psychiatric treatment aspects of AD are also clearly presented. Because the early diagnosis of the dementia process is now considered of increasing importance, we focus particularly in several chapters on early changes and preclinical conditions, such as mild cognitive impairment and predementia AD. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Alzheimer Disease. |
| 9 (RLIN) | 41209 |
| General subdivision | Medical › Neurology |
| 9 (RLIN) | 27053 |
| General subdivision | Medical / Clinical Medicine |
| 9 (RLIN) | 26816 |
| General subdivision | Medical / Neurology |
| 9 (RLIN) | 26948 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 41210 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 08/02/2022 | 616.8’31 RIC | EBS12287 | 08/02/2022 | 08/02/2022 | E-BOOKS |